The potential impact of biomarker-guided triage decisions for patients with urinary tract infections

Infection

Volumn 41, Issue 4, 2013, Pages 799-809

  Litke, A ^a   Bossart, R ^b   Regez, K ^b   Schild, U ^b   Guglielmetti, M ^b   Conca, A ^b   Schafer P ^b   Reutlinger, B ^b   Mueller, B ^a   Albrich, W C ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

Biomarkers; Triage; Urinary tract infection

Indexed keywords

PROADRENOMEDULLIN; UREA;

ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL DECISION MAKING; CLINICAL FEATURE; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FATALITY; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; UREA BLOOD LEVEL; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CLINICAL LABORATORY TECHNIQUES; CLINICAL MEDICINE; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 84881114856     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0423-1     Document Type: Article

References (35)

1. Nicolle LE. Epidemiology of urinary tract infections. Infect Med. 2001;18:153-62.
2. Curns AT, Holman RC, Sejvar JJ, Owings MF, Schonberger LB. Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. Arch Intern Med. 2005;165:2514-20.
3. Blondeau JM. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option. Drugs. 2004;64:611-28.
4. Covinsky KE, Pierluissi E, Johnston CB. Hospitalization-associated disability: "She was probably able to ambulate, but I'm not sure". JAMA. 2011;306:1782-93.
5. Chalmers JD, Al-Khairalla M, Short PM, Fardon TC, Winter JH. Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic. J Antimicrob Chemother. 2010;65:608-18.
6. Aliyu ZY, Aliyu MH, McCormick K. Determinants for hospitalization in "low-risk" community acquired pneumonia. BMC Infect Dis. 2003;3:11.
7. Labarere J, Stone RA, Scott Obrosky D, et al. Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial. J Gen Intern Med. 2006;21:745-52.
8. van Nieuwkoop C, van't Wout JW, Spelt IC, et al. Prospective cohort study of acute pyelonephritis in adults: safety of triage towards home based oral antimicrobial treatment. J Infect. 2010;60:114-21.
9. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis. 1999;29:745-58.
10. Bass PF 3rd, Jarvis JA, Mitchell CK. Urinary tract infections. Prim Care. 2003;30:41-61, v-vi.
11. Hooton TM. The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am. 2003;17:303-32.
12. Ramakrishnan K, Scheid DC. Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician. 2005;71:933-42.
13. Kim K, Lee CC, Rhee JE, et al. The effects of an institutional care map on the admission rates and medical costs in women with acute pyelonephritis. Acad Emerg Med. 2008;15:319-23.
14. Hooton TM. Clinical manifestations; diagnosis; and treatment of acute pyelonephritis. In: Calderwood SB, Baron EL, editors. UpToDate. Retrieved from http://www.uptodate.com/home/index.html.
15. Grabe M, Bjerklund-Johansen TE, Botto H, Çek M, Naber KG, Tenke P, Wagenlehner F. Guidelines on urological infections. European Association of Urology (EAU) guidelines. Edition presented at the 25th Anniversary EAU Congress, Barcelona, Spain, April 2010.
16. Nanda N, Juthani-Mehta M. Novel biomarkers for the diagnosis of urinary tract infection - a systematic review. Biomark Insights. 2009;4:111-21.
17. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011;9:107.
18. Chalupa P, Beran O, Herwald H, Kaspříková N, Holub M. Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection. 2011;39:411-7.
19. Lipinska-Gediga M, Mierzchala M, Durek G. Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance. Infection. 2012;40:303-9.
20. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Müller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care. 2005;9:R816-24.
21. Schuetz P, Wolbers M, Christ-Crain M, et al. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care. 2010;14:R106.
22. Albrich WC, Dusemund F, Rüegger K, et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis. 2011;11:112.
23. Albrich WC, Rüegger K, Dusemund F, et al. Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections. Swiss Med Wkly. 2011;141:w13237.
24. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem. 2005;51:1823-9.
25. Regeniter A, Haenni V, Risch L, et al. Urine analysis performed by flow cytometry: reference range determination and comparison to morphological findings, dipstick chemistry and bacterial culture results - a multicenter study. Clin Nephrol. 2001;55:384-92.
26. Kouri T, Fogazzi G, Gant V, Hallander H, Hofmann W, Guder WG. European urinalysis guidelines. Scand J Clin Lab Invest Suppl. 2000;60:1-96.
27. Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002;287:2701-10.
28. Fairley KF, Carson NE, Gutch RC, et al. Site of infection in acute urinary-tract infection in general practice. Lancet. 1971;2:615-8.
29. Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med. 2005;142:20-7.
30. Claessens YE, Schmidt J, Batard E, et al. Can C-reactive protein, procalcitonin and mid-regional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis? Biomarkers In Sepsis (BIS) multicentre study. Clin Microbiol Infect. 2010;16:753-60. doi: 10.1111/j.1469-0691.2009.02955.x.
31. Elkharrat D, Chastang C, Boudiaf M, Le Corre A, Raskine L, Caulin C. Relevance in the emergency department of a decisional algorithm for outpatient care of women with acute pyelonephritis. Eur J Emerg Med. 1999;6:15-20.
32. Roberts DC, McKay MP, Shaffer A. Increasing rates of emergency department visits for elderly patients in the United States, 1993 to 2003. Ann Emerg Med. 2008;51:769-74.
33. Businger AP, Kaderli R, Burghardt LR, Osinga R, Liesch M, Furrer M. Demographic changes and their implications in a nonacademic emergency department in Switzerland: an 11-year trend analysis (2000-2010) of 104,510 patients. ISRN Emerg Med. 2012:Article ID 865861;2012. doi: 10.5402/2012/865861.
34. Foxman B, Klemstine KL, Brown PD. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol. 2003;13:144-50.
35. Baehni C, Meier S, Spreiter P, et al. Which patients with lower respiratory tract infections need inpatient treatment? Perceptions of physicians, nurses, patients and relatives. BMC Pulm Med. 2010;10:12.